konferans öğesi.page.titleprefix
Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

dc.contributor.authorAcar, Ibrahim Halil
dc.contributor.authorAtalay, Figen
dc.contributor.authorDemirsoy, Esra Terzi
dc.contributor.authorCan, Ferda
dc.contributor.authorGuven, Zeynep Tugba
dc.contributor.authorCetiner, Mustafa
dc.contributor.authorTombak, Anil
dc.contributor.authorComert, Melda
dc.contributor.authorGuvenc, Birol
dc.date.accessioned2024-12-06T12:52:28Z
dc.date.available2024-12-06T12:52:28Z
dc.date.issued2023
dc.identifier.issn2152-2650
dc.identifier.urihttps://hdl.handle.net/11727/12478
dc.language.isoen
dc.publisherCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
dc.subjectdarbepoetin alfa
dc.subjectMDS
dc.subjectmyelodysplastic syndrome
dc.titleCharacteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study
dc.typeOther
dspace.entity.typeKonferans Öğesitr

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: